metoprolol has been researched along with alpha-Galactosidase A Deficiency in 2 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, J | 1 |
| Wu, C | 1 |
| Cao, J | 1 |
| Wang, L | 1 |
| Tchan, M | 1 |
| Sillence, D | 1 |
2 other studies available for metoprolol and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Fabry disease with early-onset ventricular dilation: A case report.
Topics: Adolescent; Aftercare; alpha-Galactosidase; Angiotensin-Converting Enzyme Inhibitors; Dilatation, Pa | 2020 |
Fabry disease and Factor V Leiden: a potent vascular risk combination.
Topics: Activated Protein C Resistance; alpha-Galactosidase; Aspirin; Atorvastatin; Coronary Stenosis; Defib | 2011 |